Michael Edward Thase, MD

Psychiatry
Accepting new patients
Sees patients age 18 and up
Penn Psychiatry Market Street 2nd Floor
Make an appointmentCall 800-789-7366
Penn Medicine Provider

About me

  • Director, Mood and Anxiety Section
  • Professor of Psychiatry

My education and training

  • Medical School: Ohio State University - College of Medicine
  • Residency: UPMC Presbyterian

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Thase is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Nierenberg AA., Fava M., Trivedi MH., Wisniewski SR., Thase ME., McGrath PJ., Alpert JE., Warden D., Luther JF., Niederehe G., Lebowitz B., Shores-Wilson K., Rush AJ. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.[see comment] , American Journal of Psychiatry, 163(9): 2006,1519-30; quiz 1665

Rush AJ., Kraemer HC., Sackeim HA., Fava M., Trivedi MH., Frank E., Ninan PT., Thase ME., Gelenberg AJ., Kupfer DJ., Regier DA., Rosenbaum JF., Ray O., Schatzberg AF., ACNP Task Force. Report by the ACNP Task Force on response and remission in major depressive disorder. [Review] [138 refs] , Neuropsychopharmacology, 31(9): 2006,1841-53

Brown C., Battista DR., Sereika SM., Bruehlman RD., Dunbar-Jacob J., Thase ME. How can you improve antidepressant adherence? , Journal of Family Practice, 56(5): 2007,356-63

Najavits LM., Harned MS., Gallop RJ., Butler SF., Barber JP., Thase ME., Crits-Christoph P. Six-month treatment outcomes of cocaine-dependent patients with and without PTSD in a multisite national trial , Journal of Studies on Alcohol, 68(3): 2007,353-61

Thase ME., Friedman ES., Biggs MM., Wisniewski SR., Trivedi MH., Luther JF., Fava M., Nierenberg AA., McGrath PJ., Warden D., Niederehe G., Hollon SD., Rush AJ. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report , American Journal of Psychiatry, 164(5): 2007,739-52

Wisniewski SR., Fava M., Trivedi MH., Thase ME., Warden D., Niederehe G., Friedman ES., Biggs MM., Sackeim HA., Shores-Wilson K., McGrath PJ., Lavori PW., Miyahara S., Rush AJ. Acceptability of second-step treatments to depressed outpatients: a STAR*D report , American Journal of Psychiatry, 164(5): 2007,753-60

Miklowitz DJ., Otto MW., Frank E., Reilly-Harrington NA., Wisniewski SR., Kogan JN., Nierenberg AA., Calabrese JR., Marangell LB., Gyulai L., Araga M., Gonzalez JM., Shirley ER., Thase ME., Sachs GS. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program , Archives of General Psychiatry, 64(4): 2007,419-26

Nemeroff CB., Thase ME., EPIC 014 Study Group. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients , Journal of Psychiatric Research, 41(3-4): 2007,351-9

Sachs GS., Nierenberg AA., Calabrese JR., Marangell LB., Wisniewski SR., Gyulai L., Friedman ES., Bowden CL., Fossey MD., Ostacher MJ., Ketter TA., Patel J., Hauser P., Rapport D., Martinez JM., Allen MH., Miklowitz DJ., Otto MW., Dennehy EB., Thase ME. Effectiveness of adjunctive antidepressant treatment for bipolar depression.[see comment] , New England Journal of Medicine, 356(17): 2007,1711-22

Stewart JW., Thase ME. Treating DSM-IV depression with atypical features. [Review] [16 refs] , Journal of Clinical Psychiatry, 68(4): 2007,e10